Adalimumab Imports from CHINA to India — Trade Data & Analysis

Name: CHINA to India Adalimumab Bilateral Import Data — 1 Suppliers, 1 Buyers, $377 FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

TransData Nexus

Adalimumab

India Pharmaceutical Trade Intelligence

$1.2M67 Suppliers53 CountriesHS 30021500

ExportsIndia → VENEZUELA27.9%India → SRI LANKA20.0%

ImportsUNITED STATES → India$167.7K UNITED KINGDOM → India$28.5K

#1 Supplier: RELIANCE LIFE

Adalimumab Imports from CHINA to India (2026) — $377 USD, 1 Shipments, Top Suppliers | TransData Nexus | TransData Nexus

Who Supplies Adalimumab to India from CHINA

India's adalimumab imports from CHINA total $377 across 1 shipments from 1 foreign suppliers. PIERCE BIOTECHNOLOGY,INC. leads with $377 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for adalimumab — a concentrated sourcing relationship with select suppliers from CHINA.

Source: Indian Customs (DGFT) Import Records · TransData NexusUpdated February 2026

Top foreign suppliers (CHINA) — Ranked by import value

PIERCE BIOTECHNOLOGY,INC. is the leading Adalimumab supplier from CHINA to India, with import value of $377 across 1 shipments. The top 5 suppliers — PIERCE BIOTECHNOLOGY,INC. — collectively account for 100.0% of total import value from this origin.

Top foreign suppliers (CHINA)

Ranked by import value (USD) · Indian Customs (DGFT) data

Feb 2026

Top Adalimumab suppliers from CHINA to India — ranked by import value (USD). 1 suppliers. Indian Customs (DGFT) data compiled by TransData Nexus.
#	Supplier	Value (USD)	Shipments	Share
1	PIERCE BIOTECHNOLOGY,INC.	$377	1	100.0%

Showing top 1 of 1 foreign suppliers · Indian Customs (DGFT) · TransData Nexus

Top Indian buyers (importing from CHINA)

Ranked by import value (USD)

Top Indian buyers of Adalimumab from CHINA — ranked by import value
#	Buyer	Value (USD)	Shipments	Share
1	INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED	$377	1	100.0%

Frequently Asked Questions — Adalimumab Imports from CHINA

Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus

QWho are the top Adalimumab suppliers from CHINA to India?

The top Adalimumab suppliers from CHINA to India include PIERCE BIOTECHNOLOGY,INC.. The leading supplier is PIERCE BIOTECHNOLOGY,INC. with import value of $377 USD across 1 shipments. India imported Adalimumab worth $377 USD from CHINA in total across 1 shipments.

QHow much Adalimumab does India import from CHINA?

India imported Adalimumab worth $377 USD from CHINA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.

QWho are the main Indian buyers of Adalimumab from CHINA?

The main Indian buyers of Adalimumab sourced from CHINA include INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED. The largest buyer is INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED with $377 in imports across 1 shipments.

QWhat is the total value of Adalimumab imports from CHINA to India?

The total value of Adalimumab imports from CHINA to India is $377 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).

Official References & Regulatory Resources

Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Adalimumab

Adalimumab

Who Supplies Adalimumab to India from CHINA

Top foreign suppliers (CHINA) — Ranked by import value

Top foreign suppliers (CHINA)

Top Indian buyers (importing from CHINA)

Import Statistics

Other Adalimumab Import Origins

Related Analysis

Need Details?

Frequently Asked Questions — Adalimumab Imports from CHINA

QWho are the top Adalimumab suppliers from CHINA to India?

QHow much Adalimumab does India import from CHINA?

QWho are the main Indian buyers of Adalimumab from CHINA?

QWhat is the total value of Adalimumab imports from CHINA to India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology